The FDA has approved Restylane Lyft with lidocaine for augmentation of the chin region for adults aged 21 years and older with mild to moderate chin retrusion, manufacturer Galderma announced in a ...
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Restylane Lyft with Lidocainefor ...
ZUG, Switzerland - Galderma (SIX:GALD) announced Wednesday that the U.S. Food and Drug Administration has approved Restylane Lyft with Lidocaine for chin augmentation in patients over 21 with ...
This approval is based on results showing the safety and effectiveness of Restylane Lyft in enhancing the chin profile, with high patient satisfaction and long-lasting results 1,2 Restylane Lyft is ...
“This approval reinforces our commitment to advancing our Injectable Aesthetics portfolio – the broadest on the market – to meet the diverse needs of patients. By expanding how innovations like ...
“This approval reinforces our commitment to advancing our Injectable Aesthetics portfolio – the broadest on the market – to meet the diverse needs of patients. By expanding how innovations like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback